Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection
Clinical trial NCT07709299 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07709299
- Sponsor
- Royan Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-07-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.